米国の体外診断市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、セグメント予測、2024年～2030年

米国の体外診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の体外診断市場規模は2030年までに375億8,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 3.70％で成長すると予測されています。血液、尿、組織などの生体流体の診断検査を行う医療機器は、体外診断薬（IVD）として知られています。IVD検査は、薬理療法の研究や、感染症、自己免疫疾患、様々な医学的疾患の特定と評価に使用されます。

慢性疾患や病原性疾患の有病率の上昇、人口の高齢化、ポイント・オブ・ケア検査の普及、個別化医療は、国内における体外診断用医薬品（IVD）検査の需要を増加させると予想されます。さらに、ゲノミクスとプロテオミクスの発展に伴い、分子診断学がその範囲を拡大し、新たな多様な病態特異的指標と検査を導入することで、この業界は新たな展望を見いだそうとしています。

遺伝性疾患、心血管疾患、神経疾患など、いくつかの疾患は一般的になりつつあります。心血管疾患（CVD）は米国における主要な死因であり、疾病対策予防センター（CDC）によれば、毎年推定65万9000人が死亡しています。このため、早期診断に対する国民の意識が高まり、日常的な診断が増加しており、この両者が市場全体の発展を支えています。

先進的な体外診断用医薬品の発売が市場の急拡大を後押ししています。さらに、市場参入企業や研究機関は、国内全体の疾病負担を軽減するため、新規製品の開発に積極的に取り組んでいます。例えば、2021年5月、カリフォルニア大学は超高感度分子検査を開発しました。この検査はチップ技術に基づいており、A型インフルエンザとSARS-CoV-2抗原の存在を検出できます。この検査は、PoC（Point-of-Care）検査への転換を目指し、さらに研究が進められています。

ポイントオブケア検査施設におけるIVD検査の採用は急速に増加しています。複数の企業が在宅ケア施設向け検査の立ち上げに注力していることから、業界の勢力図に変化が生じています。さらに、2021年にはFDAも在宅分子診断検査を優先しました。2021年3月、BATM Advanced Communications LimitedはCOVID-19検出用の分子診断自己検査キットの発売を発表しました。

この市場は、診断ラボが完全自動化ツールを採用するようになり、力を増しています。手動や半自動装置とは対照的に、自動化装置は拡張性に優れ、高い性能を満たし、検査技師の作業時間を短縮し、バッチテストを排除し、医師に迅速な結果を提供します。市場参入企業は、このような利点から、ますます自動化機器の構築に取り組んでいます。

さらに、検査室の自動化は、診断検査の効率と有効性を促進し、迅速化し、改善します。検体チューブの装填から全ての主要な検査分野の所見の提供まで、総合的な検査室自動化システムは検査プロセスの全ての部分を扱うことができます。より多くのメーカーがより広範な自動化の選択肢を携えて市場に参入するにつれ、臨床診断ビジネスにおけるラボ自動化の進化は加速し続けています。

SARS-CoV-2ウイルスの検出に利用されているため、COVID-19パンデミックは分子診断ツールへの需要を高めています。また、COVID-19に罹患した入院患者の間では、血糖値、トロポニン値、その他様々なパラメータを測定するための検査キットや消耗品の需要が急増しました。その結果、パンデミックの間に体外診断用医薬品の使用量が増加し、市場の成長を促進しました。

米国体外診断市場レポート・ハイライト

• 製品別では、米国では遺伝子検査の需要が増加していること、先進的ながん診断検査が利用可能であることから、試薬分野が米国体外診断用医薬品市場で大きなシェアを占めています。
• 凝固部門は急成長が見込まれます。心血管疾患、血液関連疾患、自己免疫疾患の有病率の上昇が凝固検査需要を押し上げると予想されます。
• がん分野は、有病率の上昇と疾病の早期診断に関する人々の意識の高まりにより、予測期間中に最も速いCAGRで成長すると予測されます。
• 主な市場参入企業には、QIAGEN、F. Hoffman-La Roche Ltd.、Thermo Fisher Scientific, Inc.、Danaher Corporation、Illuminaなどがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のIVD市場の変数、動向、および範囲

• IVD市場系統の見通し
  • 親市場の見通し
• 規制の枠組み
• 市場促進要因分析
  • 高齢者人口の増加
  • 技術の進歩
  • POC施設の需要の増加
  • 遺伝性疾患、心血管疾患、神経疾患、院内感染などの標的疾患の有病率の増加
  • 新型コロナウイルス感染症（COVID-19）の発生
• 市場抑制要因分析
  • デバイスのコストが高くなる
  • 厳格な規制政策
• バリューチェーン分析
  • バリューチェーン分析/市場投入までのルート
• SWOT分析、要因別（政治・法律、経済、技術）
• ポーターのファイブフォース分析

第4章 米国IVD市場 - 製品別セグメント分析、2018年～2030年

• 米国体外診断市場：製品変動分析
• 機器
  • 機器市場推計・予測、2018年～2030年
• 試薬
  • 試薬市場推計・予測、2018年～2030年
• サービス
  • サービス市場推計・予測、2018年～2030年

第5章 米国のIVD市場セグメント分析、技術別、2018年～2030年

• 体外診断市場：技術変動分析
• 免疫測定法
  • 免疫測定市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• 血液学
  • 血液学市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• 臨床化学
  • 臨床化学市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• 分子診断
  • 分子診断市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• 凝固
  • 凝固市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• 微生物学
  • 微生物学市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス
• その他
  • その他の市場推計・予測、2018年～2030年
  • 機器
  • 試薬
  • サービス

第6章 米国IVD市場：セグメント分析、最終用途別、2018年～2030年

• 体外診断市場：最終用途の変動分析
• 病院
  • 病院市場推計・予測、2018年～2030年
  • 病院市場、技術別
• 研究室
  • 研究室市場推計・予測、2018年～2030年
  • 研究室市場、技術別
• ホームケア
  • ホームケア市場推計・予測、2018年～2030年
  • ホームケア市場、技術別
• その他
  • その他の市場推計・予測、2018年～2030年
  • その他の市場、技術別

第7章 米国IVD市場：用途別セグメント分析、2018年～2030年

• 米国体外診断市場：用途変動分析
• 感染症
  • 感染症市場推計・予測、2018年～2030年
• 糖尿病
  • 糖尿病市場推計・予測、2018年～2030年
• 腫瘍学
  • 腫瘍学市場推計・予測、2018年～2030年
• 心臓病学
  • 心臓病市場推計・予測、2018年～2030年
• 腎臓学
  • 腎臓病市場推計・予測、2018年～2030年
• 自己免疫疾患
  • 自己免疫疾患市場推計・予測、2018年～2030年
• 薬物検査
  • 薬物検査市場推計・予測、2018年～2030年
• 血液疾患
  • 血液疾患市場推計・予測、2018年～2030年
• その他
  • その他の市場推計・予測、2018年～2030年

第8章 米国IVD市場：地域別セグメント分析、2018年～2030年

• 地域分析-米国のIVD市場
  • 米国のIVD市場の動向
  • 主要な国の動向
  • 米国における危険因子と主要な慢性疾患
  • 競合シナリオ
  • 規制の枠組み
  • 償還シナリオ
  • 米国のIVD市場推計・予測、2018年～2030年

第9章 競合分析

• 参入企業
  • BD
  • バイオ・ラッド・ラボラトリーズ株式会社
  • アボット
  • アジレント・技術株式会社
  • シーメンスヘルスケアGmbH
  • キアゲン
  • ビオメリュー
  • 株式会社クイデル
  • F.ホフマン・ラ・ロッシュ株式会社
• 参入企業の概要
• 財務実績
• 製品のベンチマーク
• 企業の市場シェア分析、2023年
• 戦略マッピング
  • 拡大
  • 取得
  • 製品/サービスの開始
  • その他

第10章 アナリストの視点

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Regulatory framework
• Table 4 Current oversight of diagnostic tests
• Table 5 EUA IVD tests for COVID-19 in March and April 2020 (Early Entrants)
• Table 6 List of FDA approved immunoassays during early stage of pandemic
• Table 7 List of key distributors
• Table 8 List of key emerging companies/technology disruptors/innovators
• Table 9 U.S. in vitro diagnostics market, by product, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
• Table 10 U.S. in vitro diagnostics market, by technology, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
• Table 11 U.S. in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. in vitro diagnostics market, by end-use, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)

List of Figures

• Fig. 1 U.S. in vitro diagnostics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. in vitro diagnostics market outlook (2023)
• Fig. 10 Parent market outlook, 2023
• Fig. 11 Penetration and growth prospect mapping
• Fig. 12 Taking control of the changing regulatory landscape
• Fig. 13 In vitro diagnostic market driver impact
• Fig. 14 Geriatric population in the U.S.
• Fig. 15 In vitro diagnostics market restraint impact
• Fig. 16 Market entry strategy
• Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 18 Porter's five forces analysis
• Fig. 19 Strategy mapping
• Fig. 20 U.S. in vitro diagnostics market: Product outlook and key takeaways
• Fig. 21 U.S. in vitro diagnostics market: Products movement analysis
• Fig. 22 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 23 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 U.S. in vitro diagnostics market: Technology outlook and key takeaways
• Fig. 26 U.S. in vitro diagnostics market: Technology movement analysis
• Fig. 27 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 29 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 30 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 33 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 34 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 37 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 38 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 41 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 42 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 45 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 46 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 49 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 50 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Instruments others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 53 Reagents others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 54 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 U.S. in vitro diagnostics market: End-use outlook and key takeaways
• Fig. 56 U.S. in vitro diagnostics market: End-use movement analysis
• Fig. 57 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 60 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 61 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 64 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 65 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 68 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 69 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 72 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 73 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 76 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 77 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 80 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 81 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 84 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 85 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Laboratory market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 89 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 90 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 93 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 94 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 97 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 98 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 100 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 101 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 102 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 103 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 104 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 105 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 106 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 107 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 108 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 109 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 110 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 111 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 112 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 113 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 114 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 115 Home care market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 116 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 117 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 118 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 119 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 120 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 121 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 122 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 123 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 124 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 125 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 126 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 127 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 128 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 129 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 130 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 131 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 132 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 133 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 134 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 135 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 136 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 137 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 138 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 139 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 140 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 141 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
• Fig. 142 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
• Fig. 143 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 144 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 145 U.S. in vitro diagnostics market: Application outlook and key takeaways
• Fig. 146 U.S. in vitro diagnostics market: Application movement analysis
• Fig. 147 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 148 Upper respiratory market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 149 Gastrointestinal panel testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 150 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 151 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 152 VRE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 153 Carbapenem-resistant bacteria market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 154 Flu market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 155 RSV market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 156 Candida market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 157 TB and drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 158 Meningitis cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 159 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 160 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 161 HIV market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 162 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 163 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 164 Other infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 165 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 166 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 167 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 168 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 169 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 170 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 171 Hematologic diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 172 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 173 U.S. in vitro diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 174 Competition categorization
• Fig. 175 Company market share analysis, 2023

U.S. In Vitro Diagnostics Market Growth & Trends:

The U.S. in vitro diagnostics market size is expected to reach USD 37.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 3.70% from 2024 to 2030. Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD). The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

The rising prevalence of chronic and pathogenic diseases, the aging population, the increasing popularity of point-of-care testing, and personalized medicine are anticipated to increase the demand for IVD testing in the country. Moreover, with developments in genomics & proteomics, this industry is seeing new prospects as molecular diagnostics expands its reach and introduces a new variety of condition-specific indicators and tests.

Several ailments, such as genetic, cardiovascular, and neurological disorders, are becoming more common. Cardiovascular diseases (CVDs) are the major cause of death in the U.S., killing an estimated 659,000 people each year, as per the Centers for Disease Control and Prevention (CDC). This has resulted in a significant public awareness about early diagnosis and a rise in routine diagnosis, both of which support the market's overall development.

The launch of new advanced IVD products is assisting the market's rapid expansion. Moreover, market players and research institutes are actively involved in the development of novel products to reduce the overall disease burden in the country. For instance, in May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (PoC) test.

The adoption of IVD testing at the point-of-care testing facilities is increasing rapidly. As several players are focusing on launching tests for home care facilities, there has been a shift in the industry dynamics. Moreover, in 2021, FDA also prioritized home-based molecular diagnostics tests. In March 2021, BATM Advanced Communications Limited announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19.

The market is gaining strength as diagnostic laboratories increasingly employ fully automated tools. Automated instruments, as opposed to manual and semi-automated equipment, are more expandable, meet high level of performance, reduce technologists' hands-on time, eliminate batch testing, and provide faster results to physicians. Market participants are increasingly working on building automated instruments as a result of these benefits.

Furthermore, laboratory automation facilitates, expedites, and improves the efficiency and efficacy of diagnostic tests. From loading specimen tubes to providing findings for all major laboratory disciplines, a total lab automated system can handle all parts of the testing process. As more manufacturers enter the market with broader automation choices, the evolution of lab automation in the clinical diagnostics business is continuing to accelerate.

Since it is utilized to detect the SARS-CoV-2 virus, the COVID-19 pandemic has increased the demand for molecular diagnostics tools. Additionally, among hospitalized patients suffering from COVID-19, there was a surge in demand for test kits and consumables for measuring blood glucose levels, troponin levels, and a variety of other parameters. As a result, the usage of IVD devices increased during the pandemic and propelled the market growth.

U.S. In Vitro Diagnostics Market Report Highlights:

• By product, the reagent segment held a larger share of the U.S. IVD market owing to the increasing demand for genetic testing and the availability of advanced cancer diagnostic tests in the country
• The coagulation segment is expected to be the fastest-growing segment. The rising prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases is expected to boost the demand for coagulation testing
• The oncology segment is anticipated to grow at the fastest CAGR over the forecast period owing to the increasing prevalence of disease and increasing awareness among people about early diagnosis of diseases
• A few of the key market players include QIAGEN; F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Danaher Corporation; Illumina

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 U.S. IVD Market Variables, Trends, & Scope

• 3.1 IVD Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Regulatory Framework
• 3.3 Market Driver Analysis
  • 3.3.1 Growing Geriatric Population
  • 3.3.2 Technological Advancements
  • 3.3.3 Increasing Demand For Poc Facilities
  • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
  • 3.3.5 Outbreak Of Covid-19
• 3.4 Market Restraint Analysis
  • 3.4.1 Higher Cost Of Devices
  • 3.4.2 Stringent Regulatory Policies
• 3.5 Value Chain Analysis
  • 3.5.1 Value Chain Analysis/Route To Market
• 3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
• 3.7 Porter's Five Forces Analysis

Chapter 4 U.S. IVD Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
• 4.2 Instruments
  • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.3 Reagents
  • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.4 Services
  • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 U.S. IVD Market-Segment Analysis, By Technology, 2018 - 2030 (USD Million)

• 5.1 In Vitro Diagnostics Market: Technology Movement Analysis
• 5.2 Immunoassay
  • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.2.2 Instruments
    • 5.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.2.3 Reagents
    • 5.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.2.4 Services
    • 5.2.4.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.3 Hematology
  • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3.2 Instruments
    • 5.3.2.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3.3 Reagents
    • 5.3.3.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3.4 Services
    • 5.3.4.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.4 Clinical Chemistry
  • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4.2 Instruments
    • 5.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4.3 Reagents
    • 5.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4.4 Services
    • 5.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.5 Molecular Diagnostics
  • 5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5.2 Instruments
    • 5.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5.3 Reagents
    • 5.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5.4 Services
    • 5.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.6 Coagulation
  • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6.2 Instruments
    • 5.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6.3 Reagents
    • 5.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6.4 Services
    • 5.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.7 Microbiology
  • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7.2 Instruments
    • 5.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7.3 Reagents
    • 5.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7.4 Services
    • 5.7.4.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.8 Others
  • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8.2 Instruments
    • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8.3 Reagents
    • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8.4 Services
    • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 U.S. IVD Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1 In Vitro Diagnostic Market: End-Use Movement Analysis
• 6.2 Hospitals
  • 6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.2.2 Hospitals Market, By Technology
    • 6.2.2.1 Immunoassay
    • 6.2.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.3 Hematology
    • 6.2.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.5 Clinical Chemistry
    • 6.2.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.7 Molecular Diagnostics
    • 6.2.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.9 Coagulation
    • 6.2.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.11 Microbiology
    • 6.2.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.13 Others
    • 6.2.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.3 Laboratory
  • 6.3.1 Laboratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3.2 Laboratory Market, By Technology
    • 6.3.2.1 Immunoassay
    • 6.3.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.3 Hematology
    • 6.3.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.5 Clinical Chemistry
    • 6.3.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.7 Molecular Diagnostics
    • 6.3.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.9 Coagulation
    • 6.3.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.11 Microbiology
    • 6.3.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.13 Others
    • 6.3.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.4 Home Care
  • 6.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4.2 Home Care Market, By Technology
    • 6.4.2.1 Immunoassay
    • 6.4.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.3 Hematology
    • 6.4.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.5 Clinical Chemistry
    • 6.4.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.7 Molecular Diagnostics
    • 6.4.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.9 Coagulation
    • 6.4.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.11 Microbiology
    • 6.4.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.13 Others
    • 6.4.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.5 Others
  • 6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5.2 Others Market, By Technology
    • 6.5.2.1 Immunoassay
    • 6.5.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.3 Hematology
    • 6.5.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.5 Clinical Chemistry
    • 6.5.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.7 Molecular Diagnostics
    • 6.5.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.9 Coagulation
    • 6.5.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.11 Microbiology
    • 6.5.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.13 Others
    • 6.5.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 U.S. IVD Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
• 7.2 Infectious Diseases
  • 7.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.1 Upper Respiratory
    • 7.2.1.1.1 Upper Respiratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.2 Gastrointestinal Panel Testing
    • 7.2.1.2.1 Gastrointestinal Panel Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • 7.2.1.3.1 MRSA Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.4 Clostridium Difficile
    • 7.2.1.4.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
    • 7.2.1.5.1 VRE Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.6 Carbapenem-Resistant Bacteria
    • 7.2.1.6.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.7 Flu
    • 7.2.1.7.1 Flu Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.8 Respiratory Syncytial Virus (RSV)
    • 7.2.1.8.1 RSV Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.9 Candida
    • 7.2.1.9.1 Candida Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.10 Tuberculosis (TB) And Drug-Resistant TB
    • 7.2.1.10.1 TB And Drug-Resistant TB Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.11 Meningitis
    • 7.2.1.11.1 Meningitis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.12 Chlamydia
    • 7.2.1.12.1 Chlamydia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.13 Gonorrhoea
    • 7.2.1.13.1 Gonorrhoea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.14 HIV
    • 7.2.1.14.1 HIV Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.15 Hepatitis C
    • 7.2.1.15.1 Hepatitis C Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.16 Hepatitis B
    • 7.2.1.16.1 Hepatitis B Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.1.17 Other Infectious Diseases
    • 7.2.1.17.1 Other Infectious Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.3 Diabetes
  • 7.3.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.4 Oncology
  • 7.4.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.5 Cardiology
  • 7.5.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.6 Nephrology
  • 7.6.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.7 Autoimmune Diseases
  • 7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.8 Drug Testing
  • 7.8.1 Drug Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.9 Hematologic Diseases
  • 7.9.1 Hematologic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.10 Others
  • 7.10.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 U.S. IVD Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 8.1 Regional Analysis - The U.S. IVD Market
  • 8.1.1 Trends In The U.S. IVD Market
  • 8.1.2 Key Country Dynamics
  • 8.1.3 Risk Factors And Major Chronic Diseases In The U.S.
  • 8.1.4 Competitive Scenario
  • 8.1.5 Regulatory Framework
  • 8.1.6 Reimbursement Scenario
  • 8.1.7 U.S. IVD Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Analysis

• 9.1. Participant Categorization
  • 9.1.1. BD
    • 9.1.1.1. Overview
    • 9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.1.3. Product Benchmarking
    • 9.1.1.4. Strategic Initiatives
  • 9.1.2. Bio-Rad Laboratories, Inc.
    • 9.1.2.1. Overview
    • 9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.2.3. Product Benchmarking
    • 9.1.2.4. Strategic Initiatives
  • 9.1.3. Abbott
    • 9.1.3.1. Overview
    • 9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.3.3. Product Benchmarking
    • 9.1.3.4. Strategic Initiatives
  • 9.1.4. Agilent Technologies, Inc.
    • 9.1.4.1. Overview
    • 9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.4.3. Product Benchmarking
    • 9.1.4.4. Strategic Initiatives
  • 9.1.5. Siemens Healthcare GmbH
    • 9.1.5.1. Overview
    • 9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.5.3. Product Benchmarking
    • 9.1.5.4. Strategic Initiatives
  • 9.1.6. Qiagen
    • 9.1.6.1. Overview
    • 9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.6.3. Product Benchmarking
    • 9.1.6.4. Strategic Initiatives
  • 9.1.7. bioMerieux
    • 9.1.7.1. Overview
    • 9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.7.3. Product Benchmarking
    • 9.1.7.4. Strategic Initiatives
  • 9.1.8. Quidel Corporation
    • 9.1.8.1. Overview
    • 9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.8.3. Product Benchmarking
    • 9.1.8.4. Strategic Initiatives
  • 9.1.9. F. Hoffmann-La Roche, Ltd.
    • 9.1.9.1. Overview
    • 9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.1.9.3. Product Benchmarking
    • 9.1.9.4. Strategic Initiatives
• 9.2. Participant's Overview
• 9.3. Financial Performance
• 9.4. Product Benchmarking
• 9.5. Company Market Share Analysis, 2023
• 9.6. Strategy Mapping
  • 9.6.1. Expansion
  • 9.6.2. Acquisition
  • 9.6.3. Product/Service Launch
  • 9.6.4. Others

Chapter 10. Analyst View